Age of Onset and Genetic Factors Associated With the Cardiomyopathic Phenotype of Very Long‐Chain Acyl‐CoA Dehydrogenase Deficiency: A Literature Review

Xiaofan Xu, Aiqin Song
Clinical Genetics · Wiley · 2026-11-18 · DOI: 10.1111/cge.70282

Abstract

ABSTRACT Very long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) is an autosomal recessive disorder of mitochondrial fatty acid β ‐oxidation caused by biallelic pathogenic variants in ACADVL. Its most severe form, the cardiomyopathic phenotype, presents early, progresses rapidly, and carries high mortality; yet quantitative tools for early risk stratification are lacking. We conducted a systematic review and pooled analysis of 213 published VLCADD cases to investigate the associations of age at onset, acylcarnitine profiles, and ACADVL variant types with the cardiomyopathic phenotype. Univariate analysis showed that log‐transformed age at onset, C14 acylcarnitine levels, and variant type differed significantly between the cardiomyopathic and noncardiomyopathic groups, whereas sex and C14:1 level did not. Age at onset demonstrated excellent discriminative ability (area under the curve 0.90; optimal cutoff 5.48 months, sensitivity 88.3%, specificity 83.7%). A clear genotype–phenotype gradient was observed, with carriers of two loss‐of‐function (LOF) variants showing the highest risk. In conclusion, age at onset is the most robust and discriminative marker of the cardiomyopathic phenotype, and two LOF variants identify a high‐risk subgroup. These findings support early risk stratification and targeted cardiac surveillance in VLCADD.

Read at publisher →

Similar articles